PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+9.42%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$5.41B
AUM Growth
+$1.18B
(+28%)
Cap. Flow
+$972M
Cap. Flow
% of AUM
17.96%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
1,158
New
152
Increased
697
Reduced
246
Closed
52
Top Buys
| 1 |
Alibaba
BABA
|
$59.8M |
| 2 |
JD.com
JD
|
$41.3M |
| 3 |
Mercado Libre
MELI
|
$35.1M |
| 4 |
NetEase
NTES
|
$34.7M |
| 5 |
KE Holdings
BEKE
|
$19.5M |
Top Sells
| 1 |
Futu Holdings
FUTU
|
$27.8M |
| 2 |
Trip.com Group
TCOM
|
$21.9M |
| 3 |
AOD
abrdn Total Dynamic Dividend Fund
AOD
|
$12.1M |
| 4 |
Gabelli Dividend & Income Trust
GDV
|
$12M |
| 5 |
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
|
$11.2M |
Sector Composition
| 1 | Consumer Discretionary | 33.74% |
| 2 | Technology | 22.72% |
| 3 | Communication Services | 13.35% |
| 4 | Industrials | 4.85% |
| 5 | Real Estate | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Stoke Therapeutics
STOK
$1.13B
| $31K | ﹤0.01% |
815
-15
| -2% | -$571 |
|
902
Supernus Pharmaceuticals
SUPN
$2.58B
| $31K | ﹤0.01% |
1,190
-20
| -2% | -$521 |
|
903
Zscaler
ZS
$42.7B
| $31K | ﹤0.01% |
183
+28
| +18% | +$4.74K |
|
904
Gen Digital
GEN
$18.2B
| $30K | ﹤0.01% |
1,455
+236
| +19% | +$4.87K |
|
905
W.P. Carey
WPC
$14.9B
| $30K | ﹤0.01% |
437
+65
| +17% | +$4.46K |
|
|
GSKY
906
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $30K | ﹤0.01% |
4,929
+3,286
| +200% | +$20K |
|
907
Theravance Biopharma
TBPH
$703M
| $29K | ﹤0.01% |
1,460
-5
| -0.3% | -$99 |
|
908
Y-mAbs Therapeutics
YMAB
$390M
| $29K | ﹤0.01% |
980
+50
| +5% | +$1.48K |
|
909
Allegion
ALLE
$14.8B
| $28K | ﹤0.01% |
225
+32
| +17% | +$3.98K |
|
910
Lincoln National
LNC
$7.98B
| $28K | ﹤0.01% |
457
+72
| +19% | +$4.41K |
|
911
Medical Properties Trust
MPW
$2.77B
| $28K | ﹤0.01% |
1,320
+208
| +19% | +$4.41K |
|
|
FMTX
912
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $28K | ﹤0.01% |
1,010
+65
| +7% | +$1.8K |
|
913
Altice USA
ATUS
$1.05B
| $27K | ﹤0.01% |
837
+128
| +18% | +$4.13K |
|
914
Factset
FDS
$14B
| $27K | ﹤0.01% |
89
+11
| +14% | +$3.34K |
|
915
Innoviva
INVA
$1.29B
| $27K | ﹤0.01% |
2,295
-80
| -3% | -$941 |
|
|
ITOS
916
DELISTED
iTeos Therapeutics
ITOS
| $27K | ﹤0.01% |
790
-15
| -2% | -$513 |
|
917
Jack Henry & Associates
JKHY
$11.8B
| $27K | ﹤0.01% |
183
+24
| +15% | +$3.54K |
|
918
LKQ Corp
LKQ
$8.33B
| $27K | ﹤0.01% |
655
+104
| +19% | +$4.29K |
|
919
Nurix Therapeutics
NRIX
$758M
| $27K | ﹤0.01% |
885
-5
| -0.6% | -$153 |
|
920
Ocular Therapeutix
OCUL
$2.37B
| $27K | ﹤0.01% |
1,700
+60
| +4% | +$953 |
|
921
Dayforce
DAY
$10.9B
| $27K | ﹤0.01% |
326
+51
| +19% | +$4.22K |
|
|
BKI
922
DELISTED
Black Knight, Inc. Common Stock
BKI
| $27K | ﹤0.01% |
376
+56
| +18% | +$4.02K |
|
|
TBIO
923
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $27K | ﹤0.01% |
1,680
-40
| -2% | -$643 |
|
924
Atara Biotherapeutics
ATRA
$90.7M
| $26K | ﹤0.01% |
75
+4
| +6% | +$1.39K |
|
925
Brown & Brown
BRO
$31.3B
| $26K | ﹤0.01% |
585
+88
| +18% | +$3.91K |
|